Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-23-028902
Filing Date
2023-03-06
Accepted
2023-03-06 13:05:59
Documents
6
Effectiveness Date
2023-03-06

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm238355d1_s8.htm S-8 51379
2 EXHIBIT 5.1 tm238355d1_ex5-1.htm EX-5.1 10590
3 EXHIBIT 23.2 tm238355d1_ex23-2.htm EX-23.2 1971
4 EXHIBIT 99.4 tm238355d1_ex99-4.htm EX-99.4 289684
5 EX-FILING FEES tm238355d1_ex-filingfees.htm EX-FILING FEES 14388
6 GRAPHIC tm238355d1_ex5-1img002.jpg GRAPHIC 20318
  Complete submission text file 0001104659-23-028902.txt   397233
Mailing Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103
Business Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103 2678660312
Passage BIO, Inc. (Filer) CIK: 0001787297 (see all company filings)

EIN.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270293 | Film No.: 23708357
SIC: 2836 Biological Products, (No Diagnostic Substances)